Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia

Leukemia. 2024 May;38(5):1178-1181. doi: 10.1038/s41375-024-02190-1. Epub 2024 Feb 28.

Authors

Guillermo Montalban-Bravo¹, Juan Jose Rodriguez-Sevilla², David Michael Swanson³, Rashmi Kanagal-Shamanna⁴, Danielle Hammond², Kelly Chien², Koji Sasaki², Elias Jabbour², Courtney DiNardo², Koichi Takahashi², Nicholas Short², Ghayas C Issa², Naveen Pemmaraju², Tapan Kadia², Farhad Ravandi², Naval Daver², Gautam Borthakur², Sanam Loghavi⁴, Sherry Pierce², Carlos Bueso-Ramos⁴, Hagop Kantarjian², Guillermo Garcia-Manero²

Affiliations

¹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. GMontalban1@mdanderson.org.
² Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 38418609
DOI: 10.1038/s41375-024-02190-1

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Letter

MeSH terms

Aged
Female
Humans
Leukemia, Myelomonocytic, Chronic* / genetics
Leukemia, Myelomonocytic, Chronic* / pathology
Male
Middle Aged
Mutation*
Phenotype*
Prognosis